Subsea 7 S.A.
ACGYFOTCEnergy● Active
$27.00
$-8.36(-23.64%)
Market Cap$8.0B
P/E Ratio—
52W High$35.36
52W Low$15.93
Subsea 7 S.A.（ACGYF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ACGYF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $7.29B | $6.84B | $5.97B | $5.14B | $5.01B |
| Cost of Revenue | $6.17B | $6.13B | $5.54B | $4.74B | $4.71B |
| Gross Profit | $1.12B | $0.70B | $0.43B | $0.40B | $0.30B |
| Gross Margin %(computed) | 15.38% | 10.31% | 7.24% | 7.73% | 5.90% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.01B | $0.01B | $0.01B |
| G&A Expenses | $0.00B | $0.30B | $0.07B | $0.07B | $0.07B |
| Total Operating Expenses | $0.35B | $0.26B | $0.33B | $0.25B | $0.23B |
| Operating Income | $0.77B | $0.45B | $0.10B | $0.15B | $0.07B |
| Operating Margin %(computed) | 10.58% | 6.52% | 1.75% | 2.90% | 1.43% |
| Interest Income | $0.02B | $0.02B | $0.03B | $0.01B | $0.00B |
| Interest Expense | $0.09B | $0.10B | $0.07B | $0.02B | $0.02B |
| Income Before Tax | $0.64B | $0.37B | $0.08B | $0.14B | $0.10B |
| Income Tax Expense | $0.22B | $0.15B | $0.07B | $0.10B | $0.06B |
| Net Income | $0.42B | $0.20B | $0.02B | $0.06B | $0.03B |
| Net Margin %(computed) | 5.81% | 2.95% | 0.26% | 1.11% | 0.63% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.43 | $0.68 | $0.05 | $0.19 | $0.10 |
| Wtd Avg Shares | 0.30B | 0.30B | 0.30B | 0.29B | 0.30B |
| EBITDA | $1.47B | $1.09B | $0.69B | $0.62B | $0.55B |
| EBITDA Margin %(computed) | 20.16% | 15.97% | 11.54% | 12.06% | 11.04% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B
深入了解Subsea 7 S.A.
关于Subsea 7 S.A.（ACGYF）损益表
Subsea 7 S.A.（ACGYF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，ACGYF实现营收$7.29B，毛利润$1.12B（毛利率15.38%），净利润$0.42B（净利率5.81%）。
常见问题
ACGYF · 4 问Subsea 7 S.A.（ACGYF）2025财年营收为$7.29B，同比up6.7%。
ACGYF revenueACGYF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09